Alzheimer's Disease associated pathology induced by neurotropic viral infection
嗜神经病毒感染诱发的阿尔茨海默病相关病理
基本信息
- 批准号:10381213
- 负责人:
- 金额:$ 62.72万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-30 至 2026-08-31
- 项目状态:未结题
- 来源:
- 关键词:AllelesAlternative SplicingAlzheimer&aposs DiseaseAlzheimer&aposs disease brainAlzheimer&aposs disease pathologyAlzheimer&aposs disease patientAlzheimer&aposs disease riskAmyloid beta-42Amyloid beta-Protein PrecursorAntiviral AgentsArginineAutomobile DrivingBiologicalBiological ModelsCell modelCellsCerebrumClinicalCognitiveCoupledDNADataDementiaDiseaseDisease MarkerDisease ProgressionEtiologyExclusionExonsFrequenciesGenesGeneticGenetic TranscriptionGoalsHHV-6AHerpesviridaeHerpesviridae InfectionsHerpesvirus 1HumanImpaired cognitionIndividualInfectionIntegration Host FactorsInterdisciplinary StudyInvestigationKineticsLabelLinkLyticLytic PhaseMessenger RNAModelingMonitorMutationNerve DegenerationNeurodegenerative DisordersNeurogliaNeuronsNormal tissue morphologyOrganoidsOutcomePathogenesisPathogenicityPathologyPatientsPhysiologicalPopulationPost-Translational Protein ProcessingPredispositionProductionProtein IsoformsProtein KinaseProteinsProtocols documentationRNARNA SplicingReporterResolutionRiskRunningSerineSeveritiesSpicesSynapsesSystemTauopathiesTechniquesTestingTimeTissuesTranscriptTropismUracil phosphoribosyltransferaseViralViral PathogenesisVirusVirus DiseasesWorkabeta accumulationamyloid precursor protein processingapolipoprotein E-4clinically relevantcombatestablished cell linegene correctiongenetic risk factorinduced pluripotent stem cellinsightlatent infectionmRNA Precursornervous system infectionneurotropicneurotropic virusnew therapeutic targetnovelpathogenpathogenic viruspermissivenessrelating to nervous systemsingle cell sequencingspatial relationshiptau Proteinstau aggregationtau expressiontau phosphorylationtau-1transcriptome
项目摘要
SUMMARY
Genetic risk factors for Alzheimer's Disease can predict the increased likelihood of acquiring the disease yet it
is becoming more evident that external factors are involved in the neurodegenerative disease progression.
Recently two herpesviruses have been implicated in this disorder as they have been found in diseased tissues
of Alzheimer's patients. Human herpes simplex virus 1 (HSV-1) and Human Herpesvirus 6a (HHV6a) are
neurotropic herpesviruses that establish both lytic and lifelong latent infections of the nervous system. How
these viral pathogens alter the outcome of neurodegenerative disease remains uncharacterized. Alzheimer's
Disease is marked by distinct alterations of host proteins including the misfolding of Tau. Using a novel human
iPSC-derived 3D cortical model system, we observed altered splicing of the mRNA that encodes Tau.
Additionally, we observe a viral infection dependent increase in the accumulation of phospho-Tau, a post
translational modification indicating the misfolding of Tau. These preliminary findings support the hypothesis
that viral infections directly impact the host cell microenvironment resulting in changes in Alzheimer's Disease
markers. The overarching goal of these studies is to identify infectious etiological agents that impact either the
severity or frequency of Alzheimer's Disease progression. The objective of this proposal is to define the
biological impact of neurotropic herpesvirus infections on accumulation of known drivers of Alzheimer's
disease within a physiologically relevant model system. Our first aim will identify and define viral dependent
changes within multiple host proteins involved in neurodegeneration. This will for the first time, a direct link
between neurotropic virus infections and pathogenic neurodegenerations in cells of clinical relevance. The
second aim will use novel RNA labeling protocols to profile the transcriptome from only infected cells within the
3D organoids and will utilize single cell sequencing to characterize the tropism of these neurotropic viruses.
The third aim will utilize 3D organoids that harbor known genetic risk factor mutations found in the onset of
Alzheimer's Disease and will determine if herpesviruses amplify the onset of neurodegenerative progression.
Successful completion will clearly define the viral factors that influence Alzheimer's disease and will provide
insight in pathogenic mechanisms that extend beyond Alzheimer's Disease.
概括
阿尔茨海默病的遗传风险因素可以预测患该病的可能性增加,但它
越来越明显的是,外部因素参与了神经退行性疾病的进展。
最近在患病组织中发现了两种疱疹病毒与这种疾病有关
阿尔茨海默氏症患者。人类单纯疱疹病毒 1 (HSV-1) 和人类疱疹病毒 6a (HHV6a) 是
嗜神经性疱疹病毒,可引起神经系统的溶解性感染和终生潜伏性感染。如何
这些病毒病原体改变神经退行性疾病的结果仍然未知。阿尔茨海默氏症
疾病的特点是宿主蛋白的明显改变,包括 Tau 蛋白的错误折叠。使用新奇的人类
在 iPSC 衍生的 3D 皮质模型系统中,我们观察到编码 Tau 的 mRNA 剪接发生了改变。
此外,我们观察到病毒感染依赖性磷酸-Tau 积累的增加,这是一种后
翻译修饰表明 Tau 的错误折叠。这些初步发现支持了这一假设
病毒感染直接影响宿主细胞微环境,导致阿尔茨海默病的变化
标记。这些研究的首要目标是确定影响以下任一方面的传染性病原体:
阿尔茨海默病进展的严重程度或频率。该提案的目标是定义
嗜神经性疱疹病毒感染对已知阿尔茨海默病驱动因素积累的生物学影响
生理相关模型系统内的疾病。我们的首要目标是识别和定义病毒依赖性
参与神经变性的多种宿主蛋白的变化。这将是第一次直接链接
嗜神经病毒感染与临床相关细胞中的致病性神经变性之间的关系。这
第二个目标是使用新颖的 RNA 标记方案来分析仅受感染细胞的转录组
3D 类器官,并将利用单细胞测序来表征这些嗜神经病毒的向性。
第三个目标将利用 3D 类器官,这些类器官含有在疾病发作时发现的已知遗传风险因素突变。
阿尔茨海默氏病并将确定疱疹病毒是否会放大神经退行性进展的发生。
成功完成将清楚地定义影响阿尔茨海默病的病毒因素,并将提供
对阿尔茨海默病以外的致病机制的深入了解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Eain A Murphy其他文献
Eain A Murphy的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Eain A Murphy', 18)}}的其他基金
Alzheimer's Disease associated pathology induced by neurotropic viral infection
嗜神经病毒感染诱发的阿尔茨海默病相关病理
- 批准号:
10673912 - 财政年份:2021
- 资助金额:
$ 62.72万 - 项目类别:
Antiviral responses of host mediated S-nitrosylation of viral proteins.
宿主介导的病毒蛋白 S-亚硝基化的抗病毒反应。
- 批准号:
10581612 - 财政年份:2021
- 资助金额:
$ 62.72万 - 项目类别:
Antiviral responses of host mediated S-nitrosylation of viral proteins.
宿主介导的病毒蛋白 S-亚硝基化的抗病毒反应。
- 批准号:
10376727 - 财政年份:2021
- 资助金额:
$ 62.72万 - 项目类别:
相似国自然基金
TRIM25介导的泛素化及ISGylation通过选择性剪接和糖代谢调控髓细胞分化
- 批准号:82370111
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
ac4C乙酰化修饰的HnRNP L选择性剪接EIF4G1调控糖代谢重编程介导前列腺癌免疫检查点阻断治疗无应答的机制研究
- 批准号:82303784
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
由CathepsinH介导的YAP选择性剪接在辐射诱导细胞死亡及辐射敏感性中的作用
- 批准号:82373527
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
基于scRNA-seq的RNA选择性剪接探究哺乳动物早期胚胎发育调控机制
- 批准号:62371265
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
PRMT5选择性剪接异构体通过甲基化PDCD4调控肝癌辐射敏感性的机制研究
- 批准号:82304081
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Molecular Pathogenesis of spinocerebellar ataxia type 12
12 型脊髓小脑共济失调的分子发病机制
- 批准号:
10579736 - 财政年份:2023
- 资助金额:
$ 62.72万 - 项目类别:
Genomic, Epigenomic, and Transcriptomic Mechanisms of Contributing to Alzheimer's Disease Risk in Diverse Ancestral Populations
不同祖先人群中阿尔茨海默病风险的基因组、表观基因组和转录组机制
- 批准号:
10301691 - 财政年份:2021
- 资助金额:
$ 62.72万 - 项目类别:
The role of CELF2 and its genetic variants in Alzheimer's disease
CELF2及其遗传变异在阿尔茨海默病中的作用
- 批准号:
10551196 - 财政年份:2021
- 资助金额:
$ 62.72万 - 项目类别:
Alzheimer's Disease associated pathology induced by neurotropic viral infection
嗜神经病毒感染诱发的阿尔茨海默病相关病理
- 批准号:
10673912 - 财政年份:2021
- 资助金额:
$ 62.72万 - 项目类别:
Alternative Splicing of ApoER2 in Alzheimer's Disease
阿尔茨海默病中 ApoER2 的选择性剪接
- 批准号:
10396990 - 财政年份:2021
- 资助金额:
$ 62.72万 - 项目类别: